Literature DB >> 110083

Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics.

N R Dunnick, R B Jones, J L Doppman, J Speyer, C E Myers.   

Abstract

For patients undergoing intraperitoneal ("belly bath") chemotherapy, it is useful to verify the distribution of infusion fluid. For this reason, 10 patients were examined by computed tomography (CT) after intraperitoneal instillation of dialysate mixed with water soluble contrast material. The extent of intraperitoneal distribution was assessed, and in two patients filling defects, presumably representing tumor, were identified.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 110083     DOI: 10.2214/ajr.133.2.221

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

1.  Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy.

Authors:  M Markman; W Jones; J L Lewis; S Rubin; T Hakes; B Reichman; R Barakat; J Curtin; L Almadrones; W Hoskins
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside.

Authors:  S Kirmani; S Zimm; S M Cleary; J Mowry; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Induced pneumoperitoneum in CT evaluation of peritoneal carcinomatosis.

Authors:  F Caseiro-Alves; M Gonçalo; E Abraul; E Pinto; C Oliveira; V Ramos
Journal:  Abdom Imaging       Date:  1995 Jan-Feb

Review 4.  Chemotherapy in advanced ovarian cancer.

Authors:  C J Rodenburg; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

5.  Intraperitoneal hyperthermic chemotherapy: experience at Baylor University Medical Center.

Authors:  Joseph A Kuhn; James M McLoughlin; Daniel C Harris; Loraye J Talaasen; Steven W Sutton; Todd M McCarty
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

Review 6.  Intracavitary chemotherapy for malignant disease confined to body cavities.

Authors:  M Markman
Journal:  West J Med       Date:  1985-03

7.  Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine.

Authors:  F M Muggia; K K Chan; C Russell; N Colombo; J L Speyer; K Sehgal; S Jeffers; J Sorich; L Leichman; U Beller
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 8.  Intraperitoneal therapy in the management of ovarian carcinoma.

Authors:  M Markman; T Hakes; B Reichman; W Hoskins; S Rubin; W Jones; L Almadones; J L Lewis
Journal:  Yale J Biol Med       Date:  1989 Jul-Aug

9.  The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy.

Authors:  B Ward; S Mather; J Shepherd; M Crowther; L Hawkins; K Britton; M L Slevin
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

10.  Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.

Authors:  G Los; M J van Vugt; H M Pinedo
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.